Total Syntheses of (-)-hanishin, (-)-longmide B, and (-)-longmide B Methyl Ester Via A Novel Preparation of N-Substituted Pyrrole-2-Carboxylates
Guolin Cheng,Xinyan Wang,Hailin Bao,Chuanjie Cheng,Nan Liu,Yuefei Hu
DOI: https://doi.org/10.1021/ol203433c
IF: 5.2
2012-01-01
Organic Letters
Abstract:A novel preparation of N-substituted pyrrole-2-carboxylates has been developed based upon 1,3-dipolar cycloaddition and a conventional hydrogenolysis. By using this method as the key step, total syntheses of natural alkaloids ( )-hanishin, ( )-longmide B, and ( )-longmide B methyl ester were accomplished in the highest overall yields, respectively. Pyrrole-2-carboxylic acid derivatives are a large family of natural alkaloids. Most brominated pyrrole-2-carboxamides were isolated from marine sponges, such as ( )-hanishin (1), ( )-longmide B (2), and ( )-longmide Bmethyl ester (3) (Figure 1). These alkaloids not only have a novel chiral dihydropyrrolo[1,2-a]pyrazin-1-one skeleton but also showed biologically important properties. For example, ( )-hanishin (1) was cytotoxic toward NSCLCN6 human nonsmall-cell-lung carcinoma (IC50 9.7 μg/mL); ( )-longmide B (2) displayed activity against African trypanosome (IC50 1.53 μ/mL); and (()-longmide B methyl ester (3) exhibited cytotoxic activity against P-388 lymphocytic leukemia cells (ED50 30 μg/mL), respectively. Therefore, they are highly attractive targets for the total synthesis. The first racemic total syntheses of 1 3 were accomplished a year after ( )-hanishin (1) was first isolated. Thereafter a number of enantioselective total syntheses were reported via chiral pool and asymmetric catalysis strategies. These reported routes clearly indicated that efficient total syntheses of 1 3 must resolve two major Figure 1. Three bioactive brominated pyrrole-2-carboxamides. (1) For selected references, see: (a) Bellina, F.; Rossi, R.Tetrahedron 2006, 62, 7213–7256. (b)Walsh,C. T.;Garneau-Tsodikova, S.; HowardJones, A. R. Nat. Prod. Rep. 2006, 23, 517–531. (c) Handyab, S. T.; Zhang, Y. Org. Prep. Proc. Int. 2005, 37, 411–445. (2) Mancini, I.; Guella, G.; Amade, P.; Roussakis, C.; Pietra, F. Tetrahedron Lett. 1997, 38, 6271–6274. (3) (a) Scala, F.; Fattorusso, E.;Menna,M.; Taglialatela-Scafati, O.; Tierney, M.; Kaiser, M.; Tasdemir, D. Mar. Drugs 2010, 8, 2162–2174. (b) Cafieri, F.; Fattorusso, E.; Taglialatela EScafati, O. J. Nat. Prod. 1998, 61, 122–125. (4) (a)Reddy,N. S.; Venkateswarlu,Y.Biochem.Syst. Ecol. 2000, 28, 1035–1037. (b) Umeyama, A.; Ito, S.; Yuasa, E.; Arihara, S.; Yamada, T. J. Nat. Prod. 1998, 61, 1433–1434. (5) (a) Sun, X.-T.; Chen, A. Tetrahedron Lett. 2007, 48, 3459–3461. (b) Banwell,M.G.; Bray,A.M.;Willis, A. C.;Wong,D. J.NewJ. Chem. 1999, 23, 687–690. (6) Patel, J.; Pelloux-Le0on, N.; Minassian, F.; Valle0e, Y. J. Org. Chem. 2005, 70, 9081–9084. (7) (a) Trost, B. M.; Osipov, M.; Dong, G. J. Am. Chem. Soc. 2010, 132, 15800–15807. (b) Trost, B. M.; Dong, G. Org. Lett. 2007, 9, 2357– 2359.